AB

Anastasia Budinskaya

Investor at NFX

San Francisco Bay Area

Overview

Work Experience

  • Investor

    2024 - Current

  • Co-Founder & CBO

    2023

    • Strategic Planning: Established foundation and shaped 3 pillar initiatives: multiple event series in biotech hubs; pharma to startup mentoring program; next generation career initiative. Expanding to awarding grant funding. • Program Design & Execution: Co-authored and led 5-year strategic plan centered on domestic and international expansion. Within 12 months, hosted 5,000+ lifesci professionals (VC, founder, pharma, etc.) across 8 cities through monthly events. • Business Development: Devised strategy to bring on 50+ partnerships and sponsors for projected annual $500K sponsorship.

  • Creator

    2023

    Hosting happy hours across biotech hubs

  • Senior Manager, Operations and Strategic Initiatives

    2024 - 2024

  • Venture Associate

    2022 - 2023

  • Search and Evaluation Fellow

    2022 - 2022

  • Scientific Leader, Neurology

    2021 - 2022

    Implemented the clinical technology transfer of Altropane, a next generation DAT SPECT imaging agent, into the Pharmaceutical Diagnostics business Designed and implemented USA based clinical trials with various R&D functional leaders Authored clinical, regulatory, and business case documents in collaboration with SMEs to support New Product Initiatives within the R&D neurology portfolio Developed and maintained the USA and EU scientific strategy for the Neurology imaging programs with internal teams and external partners

  • Corporate & Clinical Development

    2018 - 2021

    Facilitated partnership discussions which led to multiple offers for development and commercialization in the USA, Europe, and Japan, and resulted in a global licensing deal with GE Healthcare Conducted industry diligence, competitive landscape analysis, and represented the company at investor events. De‑risked funding by organizing successful royalty renegotiation Performed an audit and gap analysis for 7 historic sponsored studies Co‑authored patents concerning radiotracer dosing and imaging Sourced and implemented project management software based on company needs

  • Founder

    2018 - 2020

  • Control Systems Engineer Intern

    2018 - 2018

    Implemented machine learning algorithms with TensorFlow in Python to analyze data from a medical device to enhance patient safety and usability Collected a clean and reliable data set from multiple medical devices for future algorithm testing Communicated project status in weekly progress meetings with the control systems development team Evaluated the regulatory environment for the medical device industry and produced a reimbursement primer for the DEKA business development team.

Relevant Websites